Nevertheless, a significant delay in gastric emptying persisted after the second meal.73 In 2014, the FDA approved daily liraglutide and weekly semaglutide for pharmacological treatment in patients with a body mass index (BMI) exceeding 30 or greater than 27 in the presence of comorbidities, such as T2DM, hypertension, or obstructive sleep apnea.74 In Australia, liraglutide is approved for weight reduction, whereas semaglutide and dulaglutide are used off-label for obesity management.75 GLP-1 and GIP receptors expressed in the hypothalamus and brainstem nuclei regulate appetite, satiety, and energy balance.55 GLP-1 receptors are also present in the hippocampus, neocortex, spinal cord, and cerebellum.58 GLP-1RAs therapy has been associated with significantly greater weight loss in non-diabetic patients than in diabetic patients.74 For instance, in the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, weekly semaglutide administration resulted in a mean body weight reduction of 14.9% from baseline among overweight or obese non-diabetic individuals,76 a magnitude of weight loss previously observed only following bariatric surgery
with some losing as much as 68 lbs of stubborn fat in just one week .With just one dose every days
A preliminary trial of ascorbic acid as supplemental therapy for autism
Preserving muscle is essential not just for aesthetics but for long-term health and sustainable results
The hair grown under minoxidil influence typically sheds within 3-4 months of discontinuation
